Willpower of genetic variation contained in the DYRK2gene and its associations with milk traits in cattle
To rush up the progress of marker-assisted alternative (MAS) in cattle breeding, the dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2), cadherin 2 (CDH2), and kinesin member of the household 1A (KIF1A) genes had been chosen based mostly totally on our pervious genome-wide affiliation study (GWAS) analysis outcomes. DYRK2 is a kinase that can participate in cell progress and/or progress; it reveals phosphorylation train in the direction of serine, threonine, and tyrosine fragments of proteins, and it is utterly totally different from totally different protein kinases. The CDH2 gene encodes a standard cadherin, which is a member of the cadherin superfamily.
The protein encoded by KIF1A is a member of the kinesin family and performs a activity inside the transportation of membrane organelles alongside axon microtubules. We detected insertion/deletion (InDel) variation in these three candidate genes in 438 explicit particular person cattle (Xinjiang Brown cattle and Wagyu × Luxi crossbreed cattle). Solely DYRK2-P3-11 bp was polymorphic and genotyped.
The polymorphism information content material materials of DYRK2-P3-11 bp was 0.336. Correlation analyses confirmed that InDel polymorphism was significantly associated to 6 utterly totally different milk traits. These findings may assist future analyses of InDelgenotypes in cattle breeds, and tempo up the progress of MAS in cattle breeding.
ALK kinase inhibitor-1 |
|||
T6409-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: ALK kinase inhibitor-1 |
ALK kinase inhibitor-1 |
|||
T6409-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: ALK kinase inhibitor-1 |
TAO Kinase inhibitor 1 |
|||
HY-112136 | MedChemExpress | 50mg | EUR 955.2 |
TAO Kinase inhibitor 1 |
|||
T16987-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
TAO Kinase inhibitor 1 |
|||
T16987-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: TAO Kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP1 kinase inhibitor 1 |
|||
T12725-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: RIP1 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
RIP2 kinase inhibitor 1 |
|||
T12727-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: RIP2 kinase inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tpl2 Kinase Inhibitor 1 |
|||
T17145-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Tpl2 Kinase Inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
Tie2 kinase inhibitor 1 |
|||
T6335-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Tie2 kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
EGFR kinase inhibitor 1 |
|||
T63648-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: EGFR kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
Pim-1 kinase inhibitor 1 |
|||
T60972-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
|||
T12396-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: PDGFRα kinase inhibitor 1 |
Pim-1 kinase inhibitor 2 |
|||
T62001-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 2 |
|||
T62001-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 2 |
Pim-1 kinase inhibitor 3 |
|||
T61074-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1 kinase inhibitor 3 |
|||
T61074-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1 kinase inhibitor 3 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pim-1/2 kinase inhibitor 1 |
|||
T9229-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pim-1/2 kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
Pan-RAF kinase inhibitor 1 |
|||
T63386-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Pan-RAF kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
|||
T11184-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: EML4-ALK kinase inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
Protein kinase D inhibitor 1 |
|||
T61163-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: Protein kinase D inhibitor 1 |
AKT Kinase Inhibitor |
|||
A3150-10 | ApexBio | 10 mg | EUR 1363.2 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
A3150-5 | ApexBio | 5 mg | EUR 819.6 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
A3150-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 895.2 |
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
HY-10249A | MedChemExpress | 10mg | EUR 1052.4 |
AKT Kinase Inhibitor |
|||
T10276-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-1g | TargetMol Chemicals | 1g | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
AKT Kinase Inhibitor |
|||
T10276-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
|||
Description: AKT Kinase Inhibitor |
Tie2 Kinase Inhibitor |
|||
B1338-25 | Biovision | each | EUR 907.2 |
Tie2 Kinase Inhibitor |
|||
B1338-5 | Biovision | each | EUR 314.4 |
Tie2 kinase inhibitor |
|||
A5979-100 | ApexBio | 100 mg | EUR 1452 |
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38. |
Tie2 kinase inhibitor |
|||
A5979-25 | ApexBio | 25 mg | EUR 477.6 |
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38. |
Tie2 kinase inhibitor |
|||
A5979-5 | ApexBio | 5 mg | EUR 199.2 |
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38. |
Tie2 kinase inhibitor |
|||
A5979-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 536.4 |
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38. |
Tie2 kinase inhibitor |
|||
E1KS1577 | EnoGene | 10mg | EUR 1849.2 |
Sorafenib (Raf-1 kinase inhibitor) |
|||
SIH-476-10MG | Stressmarq | 10 mg | EUR 145.2 |
|
|||
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml). |
Sorafenib (Raf-1 kinase inhibitor) |
|||
SIH-476-50MG | Stressmarq | 50 mg | EUR 346.8 |
|
|||
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml). |
K252A (Kinase inhibitor) |
|||
SIH-455-100UG | Stressmarq | 100 µg | EUR 157.2 |
|
|||
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO. |
K252A (Kinase inhibitor) |
|||
SIH-455-1MG | Stressmarq | 1 mg | EUR 358.8 |
|
|||
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO. |
K252B (Kinase inhibitor) |
|||
SIH-456-100UG | Stressmarq | 100 µg | EUR 218.4 |
|
|||
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml). |
K252B (Kinase inhibitor) |
|||
SIH-456-1MG | Stressmarq | 1 mg | EUR 682.8 |
|
|||
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml). |
Genetic variants in N6-methyladenosine are associated to bladder most cancers risk inside the Chinese language language inhabitants
Not too way back N6-Methyladenosine (m6A) has been acknowledged to info the interaction of RNA-binding protein hnRNP C and their purpose RNAs, which is termed as m6A-switches. We systematically investigated the affiliation between genetic variants in m6A-switches and bladder most cancers risk. A two-stage case-control study was carried out to systematically calculate the affiliation of single nucleotide polymorphisms (SNPs) in 2798 m6A-switches with bladder most cancers risk in 3,997 subjects.
A logistic regression model was used to guage the outcomes of SNPs on bladder most cancers risk. A group of experiments had been adopted to find the operate of genetic variants of m6A-switches. We acknowledged that rs5746136 (G > A) of SOD2 in m6A-switches was significantly associated to the diminished risk of bladder most cancers (additive model in discovery stage: OR = 0.80, 95% CI 0.69-0.93, P = 3.6 × 10-3; validation stage: adjusted OR = 0.88, 95% CI 0.79-0.99, P = 3.0 × 10-2; combined analysis: adjusted OR = 0.85, 95% CI 0.78-0.93, P = 4.0 × 10-4).
The mRNA stage of SOD2 was remarkably lower in bladder most cancers tissues than the paired adjoining samples. SNP rs5746136 may affect m6A modification and regulate SOD2 expression by guiding the binding of hnRNP C to SOD2, which carried out a important tumor suppressor operate in bladder most cancers cells by promoting cell apoptosis and inhibiting proliferation, migration and invasion.
In conclusion, our findings counsel the important operate of genetic variants in m6A modification. SOD2 polymorphisms may have an effect on the expression of SOD2 by an m6A-hnRNP C-dependent mechanism and be promising predictors of bladder most cancers risk.
Weight reduction plan Modifies Pioglitazone’s Have an effect on on Hepatic PPAR γ-Regulated Mitochondrial Gene Expression
- Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose outcomes finish outcome predominantly from its modulation of the transcriptional train of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to cope with human insulin-resistant diabetes and as well as ceaselessly thought-about for remedy of nonalcoholicsteatohepatitis (NASH).
- In every settings, Pio’s useful outcomes are believed to finish outcome primarily from its actions on adipose PPARγ train, which improves insulin sensitivity and reduces the provision of fatty acids to the liver. Nonetheless, a modern medical trial confirmed variable efficacy of Pio in human NASH.
- Hepatocytes moreover particular PPARγ, and such expression will improve with insulin resistance and in nonalcoholic fatty liver sickness (NAFLD). Furthermore, mice that overexpress hepatocellular PPARγ and Pio-treated mice with extrahepatic PPARγ gene disruption develop choices of NAFLD. Thus, Pio’sdirect affect on hepatocellular gene expression may be a determinant of this drug’s remaining have an effect on on insulin resistance and NAFLD. Earlier analysis have characterised Pio’sPPARγ-dependent outcomes on hepatic expression of explicit adipogenic, lipogenic, and totally different metabolic genes.
- Nonetheless, such transcriptional regulation has not been comprehensively assessed. The analysis reported proper right here cope with that consideration by genome-wide comparisons of Pio’s hepatic transcriptional ends in wildtype (WT) and liver-specific PPARγ-knockout (KO) mice given each administration or high-fat (HFD) diets. The outcomes set up an enormous set of hepatic genes for which Pio’s liver PPARγ-dependent transcriptional outcomes are concordant with its outcomes on RXR-DNA binding in WT mice.
- These info moreover current that HFD modifies Pio’s have an effect on on a subset of such transcriptional regulation. Lastly, our findings reveal a broader have an effect on of Pio on PPARγ-dependent hepatic expression of nuclear genes encoding mitochondrial proteins than beforehand acknowledged. Taken collectively, these analysis current new insights regarding the tissue-specific mechanisms by which Pio impacts hepatic gene expression and the broad scope of this drug’s have an effect on on such regulation.
HIV-1 p24 recombinant antigen |
|||
8909 | Virostat | 100 ug | EUR 608.1 |
Description: This is HIV-1 p24 recombinant antigen for ELISA,WB. |
HIV-1 p24 recombinant antigen |
|||
9002 | Virostat | 100 ug | EUR 712.5 |
Description: This is HIV-1 p24 recombinant antigen for ELISA,WB. |
HIV-1 p24 recombinant antigen. |
|||
00174-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 p24 recombinant antigen. |
HIV-1 p24 recombinant antigen. |
|||
00174-V | Virogen | 1 MG | EUR 850 |
HIV-P24 antigen array kit |
|||
VArk-Lsx001 | Creative Biolabs | unit | Ask for price |
Description: Fourth-generation HIV immunoassays detect viral p24 protein in the blood. |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
|||
801002 | Zeptometrix | 96 Determinations | EUR 574 |
HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations) |
|||
0801002 | Zeptometrix | 96T | EUR 603 |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 p17-p24 recombinant antigen. |
HIV-1 p17-p24 recombinant antigen. |
|||
00172-V | Virogen | 1 MG | EUR 850 |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV 1 p24 core recombinant antigen |
|||
00177-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen |
|||
00177-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV 1 p24 core recombinant antigen. |
HIV 1 p24 core recombinant antigen. |
|||
00177-V | Virogen | 1 MG | EUR 850 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
0801200 | Zeptometrix | 5 X 96T | EUR 2563 |
HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations) |
|||
801200 | Zeptometrix | 5 X 96 Determinations | EUR 2330 |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
|||
801008 | Zeptometrix | 5 X 96 Determinations | EUR 2386 |
HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations) |
|||
0801008 | Zeptometrix | 5 X 96T | EUR 2505 |
Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit |
|||
EH4101 | FN Test | 96T | EUR 571.5 |
|
|||
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p24 (1947) |
|||
MAB12321-500 | The Native Antigen Company | 0.5 | EUR 671.04 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p24 |
Human HIV-1 p24 core protein (HIV-1 p24) antibody ELISA Kit |
|||
NSL1389Hu | Sunlong | 96 wells | EUR 468 |
|
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-100 | The Native Antigen Company | 0.1 | EUR 496.27 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] |
|||
REC31743-500 | The Native Antigen Company | 0.5 | EUR 1363.78 |
Description: Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected cells. |
HIV-1 p24 ELISA Kit |
|||
Z7040001 | Biochain | 1 kit | EUR 752 |
Bovine HIV-1 p24 core protein(HIV-1 p24) Anti-body ELISA Kit |
|||
NSL1181Bo | Sunlong | 96 T | EUR 528 |
|
OPEF01414-1MG - Recombinant Human Immunodeficiency Virus 1 (HIV 1-p24) Antigen |
|||
OPEF01414-1MG | Aviva Systems Biology | 1mg | EUR 2216 |
|
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-48Tests | Abebio | 48 Tests | EUR 360 |
|
|||
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
AE62582HU-96Tests | Abebio | 96 Tests | EUR 680 |
|
|||
Description: Human (Homo sapiens) |
Human HIV (1+2) antigen&antibody ELISA Kit |
|||
EK11777 | SAB | 96Т | EUR 799 |
|
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
00111-V | Virogen | 1 MG | EUR 850 |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 p17/24/gp120 antigen |
|||
00169-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. |
HIV-1 intergase antigen |
|||
00199-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
HIV-1 intergase antigen |
|||
00199-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). |
Astrovirus Antigen (Type 1) |
|||
AS02-1000 | The Native Antigen Company | 1.0 | EUR 1654.65 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
Astrovirus Antigen (Type 1) |
|||
AS02-200 | The Native Antigen Company | 0.2 | EUR 442.69 |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
Canine Adenovirus 1 Antigen |
|||
NAT41587-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
Herpes Simplex Virus 1 Antigen |
|||
HS105-1000 | The Native Antigen Company | 1.0 | EUR 1178.79 |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
Herpes Simplex Virus 1 Antigen |
|||
HS105-200 | The Native Antigen Company | 0.2 | EUR 294.7 |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
HIV-1 p24 Antibody |
|||
20-abx137062 | Abbexa |
|
|
|
HIV-1 p24 Antibody |
|||
7313-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
7313-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
|||
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
HIV-1 p24 Antibody |
|||
abx021869-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021870-1mg | Abbexa | 1 mg | EUR 760.8 |
|
HIV-1 p24 Antibody |
|||
abx021871-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021872-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021873-1mg | Abbexa | 1 mg | EUR 794.4 |
|
HIV-1 p24 Antibody |
|||
abx021882-1mg | Abbexa | 1 mg | EUR 1178.4 |
|
HIV-1 p24 Antibody |
|||
abx021883-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021886-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021887-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx021888-1mg | Abbexa | 1 mg | EUR 1220.4 |
|
HIV-1 p24 Antibody |
|||
abx023027-1ml | Abbexa | 1 ml | EUR 693.6 |
|
HIV-1 p24 Antibody |
|||
abx023925-1mg | Abbexa | 1 mg | EUR 828 |
|
HIV-1 p24 Antibody |
|||
abx023926-1mg | Abbexa | 1 mg | EUR 828 |
|
HIV-1 p24 |
|||
E5-00024 | EnoGene | 1mg | EUR 1152 |
HIV-1 p24 |
|||
E62H002 | EnoGene | 100ug | EUR 458.4 |
HIV-1 p24 |
|||
ant-152 | ProSpec Tany | 0.5mg | EUR 275 |
Description: Mouse Anti HIV-1 p24 |
HIV-1 p24 |
|||
hiv-006 | ProSpec Tany | 100µg | EUR 130 |
Description: Recombinant HIV-1 p24 |
Canine Adenovirus 1 and 2 Antigen |
|||
NAT41589-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 tat recombinant antigen full length 15 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
HIV-1 gag recombinant antigen |
|||
8934 | Virostat | 100 ug | EUR 542.86 |
Description: This is HIV-1 gag recombinant antigen for ELISA,WB. |
HIV-1 nef recombinant antigen |
|||
8941 | Virostat | 100 ug | EUR 477.6 |
Description: This is HIV-1 nef recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen, |
|||
00170-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen |
|||
8908 | Virostat | 100 ug | EUR 673.36 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
8933 | Virostat | 100 ug | EUR 477.6 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
9000 | Virostat | 100 ug | EUR 484.13 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen |
|||
9001 | Virostat | 100 ug | EUR 484.13 |
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB. |
HIV-1 gp41 recombinant antigen. |
|||
00170-V-100ugvial | Virogen | 100ug/vial | EUR 150 |
|
|||
Description: HIV-1 gp41 recombinant antigen. |
HIV-1 gp41 recombinant antigen. |
|||
00170-V | Virogen | 1 MG | EUR 850 |
Herpes Simplex Virus 1 Lysate Antigen |
|||
HS104-1000 | The Native Antigen Company | 1.0 | EUR 270.46 |
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981) |
|||
MAB12320-100 | The Native Antigen Company | 0.1 | EUR 310.01 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p17 |
Mouse Anti Human Immunodeficiency Virus (HIV-1) p17 (1981) |
|||
MAB12320-500 | The Native Antigen Company | 0.5 | EUR 770.55 |
|
|||
Description: Mouse monoclonal antibody specific for HIV-1 p17 |
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
NAT41582-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
NAT41582-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
HIV p24 Antibody |
|||
abx021867-1mg | Abbexa | 1 mg | EUR 1612.8 |
|
HIV p24 Antibody |
|||
abx021868-1mg | Abbexa | 1 mg | EUR 1612.8 |
|
Borrelia Afzelii Antigen |
|||
NAT41583-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Afzelii Antigen |
|||
NAT41583-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Garinii Antigen |
|||
NAT41584-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Borrelia Garinii Antigen |
|||
NAT41584-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
Brucella Abortus Antigen |
|||
NAT41599-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Brucella abortus lysate, produced by fermentation. |
Brucella Abortus Antigen |
|||
NAT41599-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Brucella abortus lysate, produced by fermentation. |
Candida Albicans Antigen |
|||
NAT41601-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
Candida Albicans Antigen |
|||
NAT41601-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
Canine Parvovirus Antigen |
|||
NAT41594-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Parvovirus, produced in CRFK cells. |
Canine Coronavirus Antigen |
|||
NAT41590-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Canine Coronavirus produced in A-72 cells. |
Feline Calicivirus Antigen |
|||
NAT41595-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
Description: Feline Calicivirus produced in FC 3TG cells. |